You are logged on as Guest.
RegisterLoginShopping cart (Empty)
Home
Products & Services
New Products
Literature
Support
Contact Us
About

Annexin V (human), (recombinant) (biotin conjugate)

 
ALX-209-002-T020 20 tests 106.00 USD
 
ALX-209-002-T100 100 tests 352.00 USD
 
ALX-209-002-T300 300 tests 531.00 USD
 

Product Specification

MW:~35.8kDa.
 
Quantity:20 tests/100µl; 100 tests/500µl; 300 tests/1'500µl.
 
Purity:≥98% (SDS-PAGE, HPLC)
 
Formulation:Liquid. In 50mM TRIS, pH 7.4, containing 100mM sodium chloride, 1% BSA and 0.02% sodium azide.
 
Biological Activity:Exhibits anti-phospolipase activity.
 
Source/Host:Produced in E. coli.
 
Specificity:Binds to phosphatidylserine (PS).
 
Application:Detection of apoptotic cells by flow cytometry.
 
Shipping:SHIPPED ON BLUE ICE
 
Long Term Storage:+4°C
 
Handling:Do not freeze.
 
Background / Technical Information:Flow Cytometry Protocol:- Brief centrifugation before use is recommended- Wash cells in PBS by gentle shaking or pipetting up and down- Resuspend cells in binding buffer (10mM HEPES/NaOH, pH 7.4, 140mM NaCl, 2.5mM CaCl2; filteredthrough 0.2µm pore filter); adjust cell density to 2-5x105/ml- Take 195µl cell suspension and add 5µl Annexin V-Biotin- Mix and incubate 15 minutes at room temperature- Wash cells 2x in binding buffer - Resuspend in binding buffer- Add Streptavidin-FITC- Mix and incubate for 30 minutes in the dark at room temperature- Wash cells 1x in binding buffer and resuspend in 190µl binding buffer- Add 10µl of 20µg/ml propidium iodide stock solution (end concentration 1mg/ml)- FACS analysisSwiss-Prot link P08758: Annexin V (human)AfCS Signalling Gateway link A000281 : Annexin V (mouse)
 

Product Literature References

Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers: H.A. Andree, et al.; J. Biol. Chem. 265, 4923 (1990), Abstract; Full Text
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages: V.A. Fadok, et al.; J. Immunol. 148, 2207 (1992), Abstract;
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis: G. Koopman, et al.; Blood 84, 1415 (1994), Abstract;
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V: I. Vermes, et al.; J. Immunol. Meth. 184, 39 (1995), Abstract;
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl: S. Martin, et al.; J. Exp. Med. 182, 1545 (1995), Abstract;
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro: C.H. Homburg, et al.; Blood 85, 532 (1995), Abstract;
CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cells: P. Rovere, et al.; J. Immunol. 156, 4631 (1996), Abstract;
Quantification of apoptotic cells with fluorescein isothiocyanate- labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin: A.W.M. Boersma, et al.; Cytometry 24, 123 (1996), Abstract;
Quantification of apoptotic cells with fluorescein isothiocyanate- labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin: A.W.M. Boersma, et al.; Cytometry 24, 123 (1996), Abstract;
another CS2 website
©2010 Enzo Life Sciences, Inc.,